Guardian™ Connect is the only smart* continuous glucose monitoring (CGM) system that helps patients on multiple daily injections (MDI) outsmart highs and lows. Using smart technology to predict where glucose levels are headed, the system alerts patients from 10 to 60 minutes before a glucose excursion, so they can take action in advance.Product Details
Smart CGM predicts future high and low sensor glucose events up to 60 minutes in advance and provides access to Sugar.IQ™ insights that can inform users of clinically relevant glucose patterns.
Mohan V, Jain S, Kesavadev J, et al. Use of retrospective continuous glucose monitoring for optimizing management of type 2 diabetes in India. Journal of The Association of Physicians of India, 2016: 64:16–21.
Leinung M, Nardacci E, Patel N, Bettadahalli S, Paika K, Thompson S. Benefits of short-term professional continuous glucose monitoring in clinical practice. Diabetes Technology & Therapeutics. 2013;15(9):744-747.
Allen N, Fain J, Braun B, Chipkin S. Continuous glucose monitoring counseling improves physical activity behaviors of individuals with type 2 diabetes: A randomized clinical trial. Diabetes Research and Clinical Practice. 2008;80(3):371-379.
Kesavadev J, Vigersky R, Shin J, et al. Assessing the therapeutic utility of professional continuous glucose monitoring in type 2 diabetes across various therapies: A retrospective evaluation. Advances in Therapy. 2017;34(8):1918-1927.
Kim S, Kim H, Kim T, et al. Effectiveness of 3-day continuous glucose monitoring for improving glucose control in type 2 diabetic patients in clinical practice. Diabetes & Metabolism Journal. 2014;38(6):449.